Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Autoimmune Treatment Market?

In recent times, the size of the autoimmune treatment market has considerably expanded. The market, valued at $7.72 billion in 2024, is projected to increase to $8.66 billion in 2025, representing a compound annual growth rate (CAGR) of 12.1%. The growth witnessed in the historical period is primarily due to factors such as the rising prevalence of autoimmune disorders, advances in immunology, insights from genetic research, enhanced patient awareness and advocacy, and supportive regulatory frameworks.

What Growth Rate Is Forecasted for the Autoimmune Treatment Market by 2029?

Predictions indicate a swift expansion for the autoimmune treatment market in the coming years. By 2029, the market is set to reach a valuation of $14.66 billion, with a compound annual growth rate (CAGR) of 14.1%. Factors contributing to the growth during the forecast period include the advancement of precision medicine, the development of small molecule therapies, novel pathway targeting, gene therapy breakthroughs, increased biopharmaceutical investments, and an expanding biosimilar market. Key trends set to define the era ahead include breakthroughs in targeted therapies and biologics, immunomodulatory treatments, emphasis on rare autoimmune diseases, the implementation of telemedicine and remote monitoring, regulatory measures and drug approvals, as well as the integration of digital health tools.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7863&type=smp

Which Key Companies Are Shaping the Future of the Autoimmune Treatment Market?

Major companies operating in the autoimmune treatment market are Abbott Laboratories, Amgen Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Pfizer Inc., Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Autoimmune Inc., Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Biogen Idec Inc., Bayer Schering Pharma AG, GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., Amarin Corporation PLC, AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Biohaven Pharmaceutical Holding Company Ltd., BioMarin Pharmaceutical Inc., bluebird bio Inc., Cabaletta Bio Inc., Catabasis Pharmaceuticals Inc., ChemoCentryx Inc., Coherus BioSciences Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited, Cumberland Pharmaceuticals Inc., CytoDyn Inc.

Which Factors Are Driving Demand in the Autoimmune Treatment Industry?

The rise in funding for research and development of medications for autoimmune conditions is anticipated to fuel the growth of the autoimmune treatment market. Businesses carry out research and development to foster innovation and unveil new products or services. With regard to autoimmune diseases, research and drug development pave the way for the creation of more precise, low molecular weight, orally administered immune suppressive drugs that are chemically characterized and bear acceptable tolerability for long-term treatment. For instance, Eli Lilly and Company, a pharmaceutical firm based in the US, boosted its investment in R&D from $7 billion in 2021 to $7.19 billion in 2022. This led to an expansion in its R&D expenditure in terms of revenue percentage, from 24.8% to 25.19%. Hence, the escalation in investments in the research and development of drugs stimulates the growth of the autoimmune treatment market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7863&type=smp

How Is the Autoimmune Treatment Market Segmented by Several Divisions?

The autoimmune treatment market covered in this report is segmented –

1) By Product: Consumables And Assay Kits, Instruments, Services

2) By Service Type: Consultation And Diagnosis, Therapy And monitoring, Drug development

3) By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases

4) By Drug Class: Anti-Inflammatory, Anti-Hyperglycemic, NSAIDs, Interferons, Other Drug Class

Subsegments:

1) By Consumables And Assay Kits: ELISA Kits, Reagents And Antibodies, Sample Collection Kits

2) By Instruments: Diagnostic Equipment, Imaging Systems

3) By Services: Testing And Diagnostics Services, Consultation And Support Services, Data Analysis And Interpretation Services

What are the Emerging Market Trends Driving the Growth of the Autoimmune Treatment Industry?

There is a rising trend towards technological innovation within the autoimmune treatment market. The leading firms in this industry are utilizing ground-breaking technology to secure their market positions. For example, in June 2023, the U.S. Food and Drug Administration (FDA) endorsed RYSTIGGO (rozanolixizumab-noli), a medicine developed by the Belgium-based pharmaceutical company UCB, for the management of generalized myasthenia gravis (gMG) in adults testing positive for anti-acetylcholine receptor (AchR) or anti-muscle-specific tyrosine kinase (MuSK) antibodies. The approval was fast-tracked under Priority Review. Notably, RYSTIGGO is the solitary FDA-recognized treatment for both anti-AchR and anti-MuSK antibody-positive gMG, addressing the two most common forms of this condition. This in turn could bolster healthcare provider effectiveness, enhance the success of treatment plans, and improve overall patient health.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report

Which Regions Are Driving Growth in the Autoimmune Treatment Market?

North America was the largest region in the autoimmune treatment market in 2024. The regions covered in the autoimmune treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7863

This Report Delivers Insight On:

1. How big is the autoimmune treatment market, and how is it changing globally?

2. Who are the major companies in the autoimmune treatment market, and how are they performing?

3. What are the key opportunities and risks in the autoimmune treatment market right now?

4. Which products or customer segments are growing the most in the autoimmune treatment market?

5. What factors are helping or slowing down the growth of the autoimmune treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model